298 related articles for article (PubMed ID: 15923233)
1. Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant.
Ma W; Tang C; Lai L
Biophys J; 2005 Aug; 89(2):1183-93. PubMed ID: 15923233
[TBL] [Abstract][Full Text] [Related]
2. Attempts to convert chymotrypsin to trypsin.
Venekei I; Szilágyi L; Gráf L; Rutter WJ
FEBS Lett; 1996 Jan; 379(2):143-7. PubMed ID: 8635580
[TBL] [Abstract][Full Text] [Related]
3. Trypsin: a case study in the structural determinants of enzyme specificity.
Hedstrom L
Biol Chem; 1996; 377(7-8):465-70. PubMed ID: 8922280
[TBL] [Abstract][Full Text] [Related]
4. Converting trypsin to chymotrypsin: structural determinants of S1' specificity.
Kurth T; Ullmann D; Jakubke HD; Hedstrom L
Biochemistry; 1997 Aug; 36(33):10098-104. PubMed ID: 9254605
[TBL] [Abstract][Full Text] [Related]
5. Attempts to convert chymotrypsin to trypsin.
Venekei I; Szilágyi L; Gráf L; Rutter WJ
FEBS Lett; 1996 Mar; 383(1-2):143-7. PubMed ID: 8612781
[TBL] [Abstract][Full Text] [Related]
6. Converting trypsin to chymotrypsin: the role of surface loops.
Hedstrom L; Szilagyi L; Rutter WJ
Science; 1992 Mar; 255(5049):1249-53. PubMed ID: 1546324
[TBL] [Abstract][Full Text] [Related]
7. Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant.
Hedstrom L; Perona JJ; Rutter WJ
Biochemistry; 1994 Jul; 33(29):8757-63. PubMed ID: 8038165
[TBL] [Abstract][Full Text] [Related]
8. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
Azim MK; Grossmann JG; Zaidi ZH
J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
[TBL] [Abstract][Full Text] [Related]
9. A structural model for the prostate disease marker, human prostate-specific antigen.
Villoutreix BO; Getzoff ED; Griffin JH
Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
[TBL] [Abstract][Full Text] [Related]
10. Structural origins of substrate discrimination in trypsin and chymotrypsin.
Perona JJ; Hedstrom L; Rutter WJ; Fletterick RJ
Biochemistry; 1995 Feb; 34(5):1489-99. PubMed ID: 7849008
[TBL] [Abstract][Full Text] [Related]
11. Converting trypsin to chymotrypsin: ground-state binding does not determine substrate specificity.
Hedstrom L; Farr-Jones S; Kettner CA; Rutter WJ
Biochemistry; 1994 Jul; 33(29):8764-9. PubMed ID: 8038166
[TBL] [Abstract][Full Text] [Related]
12. The role of disulfide bond C191-C220 in trypsin and chymotrypsin.
Várallyay E; Lengyel Z; Gráf L; Szilágyi L
Biochem Biophys Res Commun; 1997 Jan; 230(3):592-6. PubMed ID: 9015368
[TBL] [Abstract][Full Text] [Related]
13. Three dimensional structures of S189D chymotrypsin and D189S trypsin mutants: the effect of polarity at site 189 on a protease-specific stabilization of the substrate-binding site.
Szabó E; Venekei I; Böcskei Z; Náray-Szabó G; Gráf L
J Mol Biol; 2003 Aug; 331(5):1121-30. PubMed ID: 12927546
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of bovine duodenase, a serine protease, with dual trypsin and chymotrypsin-like specificities.
Pletnev VZ; Zamolodchikova TS; Pangborn WA; Duax WL
Proteins; 2000 Oct; 41(1):8-16. PubMed ID: 10944388
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for broad substrate specificity of earthworm fibrinolytic enzyme component A.
Wang C; Wang F; Li M; Tang Y; Zhang JP; Gui LL; An XM; Chang WR
Biochem Biophys Res Commun; 2004 Dec; 325(3):877-82. PubMed ID: 15541372
[TBL] [Abstract][Full Text] [Related]
18. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
19. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.
Harmat V; Gál P; Kardos J; Szilágyi K; Ambrus G; Végh B; Náray-Szabó G; Závodszky P
J Mol Biol; 2004 Oct; 342(5):1533-46. PubMed ID: 15364579
[TBL] [Abstract][Full Text] [Related]
20. Ala226 to Gly and Ser189 to Asp mutations convert rat chymotrypsin B to a trypsin-like protease.
Jelinek B; Antal J; Venekei I; Gráf L
Protein Eng Des Sel; 2004 Feb; 17(2):127-31. PubMed ID: 15047908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
